Clinical Trial Update: Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing methotrexate to paclitaxel in advanced head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer | Phase 3 | Status: COMPLETED